Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.
Saved in:
| Title: | Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression. |
|---|---|
| Authors: | Kushner MH; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Ory V; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Graham GT; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Sharif GM; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Kietzman WB; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Thevissen S; Department of Molecular Medicine, Goethe University, Frankfurt am Main, Germany., Yuan M; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Schmidt MO; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Wellstein A; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA., Riegel AT; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. |
| Source: | EMBO reports [EMBO Rep] 2020 Jan 07; Vol. 21 (1), pp. e48741. Date of Electronic Publication: 2019 Dec 02. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1469-3178 |
|---|---|
| DOI: | 10.15252/embr.201948741 |
